PACIRA BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Pacira BioSciences, Inc. - PCRX
Portfolio Pulse from
Kahn Swick & Foti, LLC reminds investors of the March 14, 2025 deadline to file lead plaintiff applications in a class action lawsuit against Pacira BioSciences, Inc. (PCRX) for securities purchased between August 2, 2023, and August 8, 2024.
March 11, 2025 | 2:45 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Pacira BioSciences faces a class action lawsuit with a lead plaintiff deadline of March 14, 2025, for securities purchased during the specified period. This legal action could impact investor sentiment and stock price.
The class action lawsuit against Pacira BioSciences is significant as it involves potential financial losses for investors who purchased securities during the specified period. Legal issues can negatively impact investor sentiment and lead to stock price volatility.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100